These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4133425)

  • 1. Editorial: The thyroid, prolactin, and breast cancer.
    Lancet; 1974 May; 1(7863):908-9. PubMed ID: 4133425
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid function in patients with breast cancer.
    Perry M; Goldie DJ; Self M
    Ann R Coll Surg Engl; 1978 Jul; 60(4):290-3. PubMed ID: 666232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum.
    Adami HO; Rimsten A; Thorén L; Vegelius J; Wide L
    Acta Chir Scand; 1978; 144(2):89-97. PubMed ID: 665106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indices of thyroid activity in patients with breast cancer].
    Sidorenko LN; Popova SP; Borina ZN; Egor'kova AS; Korovin KF
    Vopr Onkol; 1984; 30(11):30-3. PubMed ID: 6440353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thyroid, prolactin, and breast cancer.
    VanderLaan WP; Larson BA
    Arch Intern Med; 1978 Nov; 138(11):1611-2. PubMed ID: 718308
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1996; 16(4A):2069-72. PubMed ID: 8712744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function in patients with benign and malignant breast disease.
    MacFarlane IA; Robinson EL; Bush H; Durning P; Howat JM; Beardwell CG; Shalet SM
    Br J Cancer; 1980 Mar; 41(3):478-80. PubMed ID: 7387836
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyroid gland function in women with breast carcinoma].
    Límanová Z; Barkmanová J; Friedmannová Z; Kasparová E; Tichá E; Spanlangová I; Jelínková A
    Vnitr Lek; 1996 Sep; 42(9):605-9. PubMed ID: 8984766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an association between thyroid function abnormalities and breast cancer?
    Angelousi A; Diamanti-Kandarakis E; Zapanti E; Nonni A; Ktenas E; Mantzou A; Kontzoglou K; Kouraklis G
    Arch Endocrinol Metab; 2017; 61(1):54-61. PubMed ID: 28273204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrocystic disease of breast and pituitary-thyroid axis function].
    Zych F; Mizia-Stec K; Mucha Z; Zych-Twardowska E
    Pol Merkur Lekarski; 1996 Oct; 1(4):227-8. PubMed ID: 9156929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-thyroid axis in breast cancer.
    Mittra I; Hayward JL
    Lancet; 1974 May; 1(7863):885-9. PubMed ID: 4133416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thyroid function in breast cancer patients].
    Dryzhak VI
    Vopr Onkol; 1993; 39(4-6):211-2. PubMed ID: 7975399
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased serum thyrotropin induced by fasting.
    Croxson MS; Hall TD; Kletzky OA; Jaramillo JE; Nicoloff JT
    J Clin Endocrinol Metab; 1977 Sep; 45(3):560-8. PubMed ID: 903402
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thyroid gland function on breast neoplasms].
    Abe R; Taneichi Y; Kumagaya N; Terui K
    Horumon To Rinsho; 1975 Feb; 23(2):133-6. PubMed ID: 1170034
    [No Abstract]   [Full Text] [Related]  

  • 17. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in thyrotropin, triiodothyronine, thyroxine and prolactin levels during septic shock in rats.
    Hadjikostova H; Petkova M; Nicolov N; Zaharieva B
    Agressologie; 1989; 30(9-10):521-3. PubMed ID: 2624301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyroid and hypophyseal function during radiation therapy of breast cancer].
    Iakimova TP; Lozinskaia IN
    Med Radiol (Mosk); 1984 Apr; 29(4):55-8. PubMed ID: 6371436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tertiary hypothyroidism in idiopathic and acquired adeno-pituitary insufficiency].
    Pavía C; Webb S; Ferrer I; Martín MR; Valls C; Palou A
    Med Clin (Barc); 1983 Dec; 81(18):801-4. PubMed ID: 6418995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.